Thank you for your responses to the first question. Now, for Day 2, I would like to delve into the dosing of adnexanet alfa. In the study, the participants received apixaban 5mg BID for 3.5 days, followed by adnexanet alfa 3 hours after the last dose. Adnexanet alfa was given as a 400mg bolus (part 1) or a 400mg bolus followed by a 4mg/min continuous infusion for 120 minutes (part 2). The rivaroxaban study was performed in a similar manner with participants receiving rivaroxaban 20mg daily for 4 days and adnexanet alfa 4 hours after the last dose, but participants received twice the dose of adnexanet alfa.
Dr. Crowther, can you please explain why there are different doses of adnexanet alfa for the different DOACs? Furthermore, patients treated for acute VTE are treated with rivaroxaban 15mg BID for 21 days and apixaban 10mg BID for 7 days. It seems that the dose of adnexanet in this study would not apply to patients who are on these higher doses.
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this challenge
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.